O ur preference for "attractive" faces is welldocumented, and is present in infants from birth. 1 The preference continues through adulthood, with attractive individuals experiencing greater social, 2 occupational, 3 and dating 4 success than their less attractive counterparts. Despite individual differences in the specifics of the faces that we each find attractive, we are generally consistent in identifying attractiveness. 5 According to evolutionary psychologists, our preference for attractive faces serves an adaptive function: encouraging us to choose high-quality mates for the propagation of our genes.
We show consistent preferences, for example, for cues to good health in the face (e.g., symmetry 6 and averageness 7 ). We also tend to perceive younger adult faces as more attractive than older faces, perhaps due to the link between youth and fertility. 8 Given the value we attribute to attractiveness and a youthful appearance, it is no surprise that facial rejuvenation approaches target signs of aging. 9 During aging, upper facial regions lose collagen and elasticity, causing skin sagging. 10 Repetitive muscular contraction leads to the development of upper dynamic facial lines, predominantly in the glabellar ("frown"), forehead ("raise eyebrows") and crows feet ("big smile") areas. 11 These areas, then, have been the target of rejuvenation techniques, among which Botulinum Toxin Type A (BoNT-A) is the most popular nonsurgical treatment worldwide. 20 This noninvasive injectable acts as a muscle relaxant, blocking the release of the neurotransmitter acetylcholine, a key messenger for muscle contractions, 12 so reducing or eradicating the appearance of upper dynamic facial lines for 8 to 12 weeks, and can also be used to correct asymmetry and raise the brow (Dayan and colleagues, 2010) . The popularity of BoNT-A treatments is evidenced by 80% to 90% of patients reporting satisfaction with their treatment, and many stating they would recommend the treatment to others. 13, 14 In addition to satisfaction with appearance post-treatment, there is a growing body of evidence that treatment with BoNT-A results in improved psychological outcomes, such as self-esteem. 15 Lewis and Bowler, 16 for example, report that patients treated with BoNT-A had significantly better mood than those treated with another cosmetic procedure. According to Jandhyala, 17 however, the most powerful way to assess the effect of BoNT-A on patient psychological wellbeing is to compare validated measures before and after treatment. Dayan and colleagues, 18 for example, in their double blind, randomized, placebo-controlled study demonstrated that participants treated with BoNT-A showed a significant improvement in self-reported measures on standardized scales of quality of life and self-esteem, compared with those in a placebo group (i.e., injected with saline).
Dayan and colleagues 18 argue that the psychological effects of BoNT-A exist for 1 of 2 reasons: (1) the physical improvement of patient's wrinkle concerns contributes to self-esteem, or (2) more favorable treatment from others, as a result of BoNT-A, encourages greater self-esteem. Both of these seem plausible, particularly in light of the human preferences for attractive faces discussed above. Thus, perhaps the effects of BoNT-A involve an interaction between both mechanisms, wherein a patient treated with BoNT-A experiences increased satisfaction with their appearance directly which, in turn (and in combination with putative direct effects of BoNT-A on attractiveness), causes them to interact more positively with others, leading them to be perceived as more attractive. This attractiveness preference may then encourage more favorable treatment towards the BoNT-A patient, reinforcing the boost to self-esteem. Subjective patient reports support this assumption; with patients revealing that they felt others treated them more favorably following BoNT-A treatment. 19 Indeed, there is even evidence that faces treated with BoNT-A are perceived as more positive for predicted academic performance, occupation, dating and athletic success, and attractiveness. 19 To summarize, BoNT-A improves objectively rated facial attractiveness 19, 20 which may contribute to
BoNT-A patients' improved psychological wellbeing following treatment. However, no previous work has assessed the same patient sample (i.e., patient self-esteem and other's perception of that patient post-BoNT-A) in order to make these inferences. Our study, then, is a controlled experiment using validated psychological measures and pretreatment and post-treatment comparison to test the following predictions: (1) treatment with BoNT-A will improve psychological wellbeing; (2) treatment with BoNT-A will improve attractiveness rated by self and others; (3) attractiveness rated by self and others will mediate the effects of BoNT-A on psychological wellbeing.
We tested the predictions in a sample of female participants using a repeated-measures design. We measured self-esteem, satisfaction with life, and self-rated attractiveness prior to, and 4 weeks (63 days) post, BoNT-A treatment. We took facial photographs at both time points, and these were rated for attractiveness by participants who were unfamiliar with those in the photographs.
Methods

Participants
We recruited 32 female participants aged 27 to 72 (mean = 41.66, SD = 12.48) from Fresh Inc MediSpa, Invergowrie, Scotland (Table 1) . Volunteers were denied participation if they had a medical condition that would contraindicate BoNT-A treatment, the presenting lines were not suitable for BoNT-A treatment, or they had previously received a treatment that would interfere with BoNT-A's treatment outcome. For 7 participants (21.88%) this was their first treatment with BoNT-A. The remainder (78.12%) had not been treated in the past 6 months.
Materials
Participants receiving BoNT-A treatment completed standardized measures of self-esteem, satisfaction with life, and self-rated attractiveness.
Self-esteem was assessed using Rosenberg's 21 SelfEsteem Questionnaire, which includes statements such as "On the whole, I am satisfied with myself" and provides a measure of the extent to which an individual values themselves.
Satisfaction with Life was measured using Deiner's Satisfaction with Life Questionnaire, 22 which is a 5-item questionnaire, including items such as "In most ways my life is close to my ideal."
To assess self-rated attractiveness before and after treatment, patients were simply asked "How attractive do you perceive yourself to be?" Responses were scored on a 5-point scale, ranging from unattractive (scored as 1) to attractive (scored as 5). This is standard in the facial attractiveness literature (e.g., Little and colleagues 5 ).
Facial Attractiveness
Facial images were collected using an iPhone 5S camera, at 1 m distance from the patient, against a white background and under standardized lighting. We instructed participants to wear consistent makeup and hairstyles for photographs taken pretreatment and post-treatment, and to maintain a neutral facial expression. Facial images were masked using Psychomorph software 23 to disguise clothes, hair, and jewelry. Thirty-one participants provided consent for their photos to be rated for attractiveness pretreatment and post-treatment.
Raters were 22 men and 78 women (mean age = 28.51, SD = 11.39) recruited via social media from the Universities of Liverpool and Nottingham Trent, in order to avoid familiarity with participants in the BoNT-A trial. We provided participants with a link which allocated them at random to rate either the pretreatment or post-treatment faces. There were 50 raters for each set of images. Faces were presented in random order via an online survey, and raters were asked to rate each face from 1 (very unattractive) to 7 (very attractive). Raters were naive to the purpose of the study and were not informed that either condition consisted of post-BoNT-A images. They were fully debriefed at the end of the study.
Procedure
The study received full approval from the University of Dundee Research Ethics Committee and the owner and manager of Fresh, Inc. MediSpa.
In-clinic appointments were scheduled for patients who expressed an interest in participating in the study.
Patients were required to attend the clinic on 3 occasions. 
T R E A T M E N T W I T H B O N T -A I M P R O V E S W E L L B E I N G
Session 1
We presented potential participants the clinic's "General Consultation Questionnaire" and Azzalure's Treatment Consent Form in accordance with clinic protocol. Upon completion, patients were seen by the in-house general practitioner (GP) to assess their medical fitness for BoNT-A treatment.
Once GP approval was given, we provided participants with a Participant Information Sheet and Consent Form, and obtained consent from the GP and senior practitioner. Participants completed the psychological wellbeing measures followed by facial photography. We then took them to the treatment room for the BoNT-A therapy. To ensure consistency of treatment procedure, the senior practitioner conducted all BoNT-A treatments. Each vial containing 125 speywood units of Azzalure (Galderma) was diluted with 0.63 mL of Bacteriostatic Saline, following reconstitution directions as instructed in Azzalure's manual. 24 There was no standardized treatment protocol, and injections depended upon participants' muscle activity, depth of lines, and the areas treated. Therefore, a record was kept of the number of areas treated, and the units injected, for each participant. Treatment areas were limited to the glabellar area, forehead and crow's feet.
Session 2
Participants returned to the clinic 2-weeks postBoNT-A treatment for a scheduled review. Any further injections, if required, were administered at this stage.
Session 3
Patients returned to the clinic 4 weeks (63 days) after the initial BoNT-A treatment. Participants completed measures of psychological wellbeing and had their photograph taken as for Session 1. Participants were then fully debriefed.
Results
All variables were within specified parameters of normality, so parametric analyses were employed. As age, number of areas treated, and number of units injected were not correlated with the variables of interest (all p > .09), we did not include these in further analyses.
Does Treatment With BoNT-A Improve Psychological Wellbeing?
In bivariate regression models, a treatment-level dummy variable (0 = pretreatment, 1 = post-treatment) was found to significantly predict self-esteem (Adj R 2 = 0.24, F(1, 62) = 20.4, p < .001, b = 0.5, p < .001) and satisfaction with life (Adj R 2 = 0.22, F(1, 62) = 18.27, p < .001, b = 0.48, p < .001), such that both were significantly higher post-treatment. Figure 1 shows the significant effects of treatment on self-esteem and satisfaction with life. 
Does Treatment With BoNT-A Improve Attractiveness Rated by Self and Others?
In bivariate regression models, a treatment-level dummy variable (0 = pretreatment, 1 = post-treatment) was found to significantly predict attractiveness rated by self (Adj R 2 = 0.36, F(1, 62) = 35.72, p < .001, b = 0.61, p < .001) and attractiveness rated by others (Adj R 2 = 0.49, F(1, 60) = 58.63, p < .001, b = 0.7, p < .001), such that both were significantly higher posttreatment. Figure 2 shows the significant effects of treatment on attractiveness rated by both self and others Figure 2 .
Does Attractiveness Mediate the Effects of Treatment With
BoNT-A on Psychological Wellbeing?
As described above, treatment significantly predicted psychological wellbeing and attractiveness. In order to determine whether attractiveness mediated the effects of treatment on psychological wellbeing, we first tested for bivariate relationships between measures of psychological wellbeing and attractiveness. Self-rated attractiveness significantly predicted self-esteem (Adj (Table 2 ).
Discussion
Here we have shown that treatment with BoNT-A results in significant improvements to psychological wellbeing (self-esteem and satisfaction with life) and attractiveness (as rated by self and others), and that the effects of treatment on self-esteem occur via the effects of treatment on attractiveness rated by self.
Our results are consistent with previous work which has reported benefits of BoNT-A for of psychological wellbeing (e.g., Dayan and colleagues 18 ). Our study, however, was also able to detect positive effects on wellbeing that extended those beyond quality-of-life measures specific to cosmetic treatment, and demonstrate that treatment with BoNT-A has benefits on life satisfaction more broadly. Furthermore, our study was the first to test the effects of BoNT-A on attractiveness rated by self and others, and to determine whether it was these effects which, in turn, accounted for the positive influence of treatment on psychological wellbeing.
As we argued earlier, there are 2 pathways by which effects of BoNT-A on attractiveness may be translated into effects on psychological wellbeing. In the first, individuals who are perceived as "attractive" may receive more favorable treatment from others which, in turn, may provide an intermediate "mediating" step between treatment with BoNT-A and psychological wellbeing: if treatment causes others to perceive the individual as more attractive and, therefore, treat them more favorably in social interactions, this may lead to improved psychological wellbeing. 19 Our analyses, however, failed to detect this effect, as attractiveness rated by others did not mediate relationships between treatment and selfesteem or satisfaction with life. In the second, the positive effects of treatment with BoNT-A on selfrated attractiveness are responsible for the positive effects of treatment on psychological wellbeing: given the value placed on "attractiveness," feeling more attractive is predicted to boost an individual's psychological wellbeing. We found support for this as self-rated attractiveness mediated the effects of treatment on self-esteem. In other words, treatment improves self-rated attractiveness which, in turn, improves self-esteem. We did not find a mediating role of self-rated attractiveness in the effect of treatment on satisfaction with life, and it may be that this variable is too broad and comprised of too much that is external to, and unaffected by, physical appearance Other-rated and self-rated attractiveness will mediate the effects of BoNT-A on psychological wellbeing Partially Self-rated attractiveness mediated the effect of treatment on self-esteem for such effects to be detected. Indeed, Dayan and colleagues 19 argue that a fundamental facet of selfesteem is an individual's attitude to their own aesthetic appearance. If they are dissatisfied with how they look, or consider themselves unattractive, they are more likely to possess low self-esteem. Our results support this, and show that treatment with BoNT-A has a positive influence on self-perceived attractiveness and, in turn, self-esteem.
Results of the current study are encouraging for the field of aesthetic medicine, highlighting the success of BoNT-A for the improvement of psychological wellbeing. We acknowledge, however, that a placebocontrolled double-blind methodology would provide a more rigorous test of our predictions. We suggest that future work should test the pathways we have identified here in clinical populations that are characterized by low self-esteem (e.g., eating disorders and depression).
In conclusion, we have demonstrated that treatment with BoNT-A results in significant improvements to psychological wellbeing (self-esteem and satisfaction with life) and attractiveness (as rated by self and others), and that the effects of treatment on self-esteem occur via the effects of treatment on self-rated attractiveness. We conclude that treatment with BoNT-A has benefits for psychological wellbeing and facial appearance, both as perceived by the self and by others.
